Relationships Among Depression, PTSD, Methamphetamine Abuse, and Psychosis

Lecomte, Tania; Paquin, Karine; Mueser, Kim T.; MacEwan, G. William; Goldner, Elliot M.; Thornton, Allen E.; Brink, Johann; Lang, Donna J.; Kang, Shimi; Barr, Alasdair M.; Honer, William G.

doi:10.1080/15504263.2013.778930

Cited by 12 publications

(7 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Methamphetamine dependence has been identified as an area of concern in many parts of the world (De-Carolis et al, 2015;McKetin et al, 2014;UNODC, 2015). In western nations, a range of poor health and social outcomes have been associated with methamphetamine use (McKetin et al, 2014) (Lecomte et al, 2013) (Cherner et al, 2010;Henry et al, 2010;Panenka et al, 2013) (Darke et al, 2008;Marshall et al, 2011) (Callaghan et al, 2012). Similar issues have also been identified in south-east Asia (DiMiceli et al, 2016) (Liao et al, 2014;Liao et al, 2013) (Zhang et al, 2014) (Liao et al, 2014).…”

Section: Introductionmentioning

confidence: 74%

“…Social stigma and shame/embarrassment as barriers to accessing treatment (Kenny et al, 2011;Meade et al, 2015;Wright et al, 1999) is consistent with previous findings that stigma affects health workers' perceptions of clients with SUD (Van Boekel et al, 2013). Stigma could be attributed to: extremely poor health (Lecomte et al, 2013); social issues, such as violence (McKetin et al, 2014); and media campaigns sensationalising the deleterious health, social and justice outcomes associated with methamphetamine use in a way likely to stigmatise, rather than assist methamphetamine users (Australian Government, 2016; Meth Project Foundation, 2016; Multnomah County Sherrif's Office, 2016)(Australian Federation of Aids Organisations, 2015; Kiejda, 2015). Prior literature suggests that campaigns that utilise shock or fear with the aim of changing behaviours, must also emphasise the treatment options available in order to be effective (Bayer and Fairchild, 2016;Soames Job, 1988).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis

Cumming

Troeung

Young

et al. 2016

Drug and Alcohol Dependence

View full text Add to dashboard Cite

The primary barriers to accessing methamphetamine treatment are psychosocial/internal. Services and treatment models that address these barriers are urgently required. There is a growing need for methamphetamine-appropriate treatment services. Further research evaluating treatment engagement and effectiveness for methamphetamine and polysubstance use, including the development of effective pharmacotherapies is warranted.

show abstract

Section: Introductionmentioning

confidence: 74%

Section: Discussionmentioning

confidence: 99%

Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis

Cumming

Troeung

Young

et al. 2016

Drug and Alcohol Dependence

View full text Add to dashboard Cite

show abstract

“…In a longitudinal study, Lecomte et al [16] considered 295 ATS users who presented with depressive or psychotic symptoms. She concluded that depression, psychosis, PTSD and substance abuse appeared to be intertwined in their development and expression.…”

Section: Clinical Aspectsmentioning

confidence: 99%

The impact of amphetamine-type stimulants on emergency services

Fulde

Forster

2015

Current Opinion in Psychiatry

View full text Add to dashboard Cite

show abstract

“…Multiple health and social problems are associated with ATS use. These include poor mental health (including depression, psychosis and suicidal behaviour),3–5 hypertension and cardiovascular problems,6 violence perpetration,7 and contact with the criminal justice system 8 9. Accordingly, there is emerging evidence of increasing ATS-related hospitalisations and health service use in many parts of the world,8 10 placing excess strain on already overburdened services sectors.…”

Section: Introductionmentioning

confidence: 99%

Amphetamine-type stimulant use and self-harm: protocol for a systematic review of observational studies

et al. 2022

View full text Add to dashboard Cite

IntroductionAmphetamine type stimulant (ATS) use and self-harm are both major public health concerns globally. Use of ATS is associated with a range of health and social problems, and has been increasing internationally in the last decade. Self-harm and ATS use share a number of underlying risk factors and occur at elevated rates in marginalised groups with high rates of exposure to trauma. The relationship between self-harm and ATS use is likely complex, and the causal pathway may run in either direction. A comprehensive review, synthesis and analysis of the evidence are warranted to investigate this relationship and inform policy and practice.Methods and analysisWe will search the Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, PsycINFO and Scopus databases for relevant observational studies published in peer-reviewed journals. The initial search was conducted on 5 February 2021, with a final search expected on 1 February 2022. All studies will be independently screened by two reviewers, first on title and abstract, and then on full-text to determine inclusion in the review. We place no restriction on the population that studies investigate, our exposure of interest is both prescription and illicit ATS use, comparators will be those not currently using ATS, and our primary outcome of interest is the prevalence of self-harm. Data will be extracted using a predesigned template, and pooled prevalence and pooled measures of effect for the association between ATS use and self-harm. If sufficient data are available, we will perform multiple meta-analyses to produce pooled measures of effect for each measure of ATS exposure, as well as different population sub-groups. The Methodological Standard for Epidemiological Research scale will be used to assess study quality, and Egger’s test and I2 values will be used to assess publication bias and heterogeneity, respectively.Ethics and disseminationNo ethical approval is required for this review. We will only synthesise information from published studies that were conducted with ethical approval, so no individual participant data will be used. We will disseminate our findings via publication in a peer-reviewed journal, national and international conference presentations, and presentations to stakeholders in the community.Trial registration numberThis study has been registered with the International Prospective Register of Systematic Reviews (PROSPERO; CRD42021226562).

show abstract

Relationships Among Depression, PTSD, Methamphetamine Abuse, and Psychosis

Cited by 12 publications

References 42 publications

Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis

Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis

The impact of amphetamine-type stimulants on emergency services

Amphetamine-type stimulant use and self-harm: protocol for a systematic review of observational studies

Contact Info

Product

Resources

About